Literature DB >> 25436186

Expression and purification of functional human vascular endothelial growth factor-a121; the most important angiogenesis factor.

Fatemeh Kazemi-Lomedasht1, Mahdi Behdani1, Kamran Pooshang Bagheri1, Mahdi Habibi Anbouhi2, Mohsen Abolhassani3, Hossein Khanahmad1, Delavar Shahbazzadeh1, Hasan Mirzahoseini1.   

Abstract

PURPOSE: Angiogenesis or formation of new blood vessels is an essential process for tumor growth, invasion and metastasis. Vascular Endothelial Growth Factor (VEGF) and its receptors play an important role in angiogenesis-dependent tumors. VEGF-A is the most important factor in angiogenesis process. Human VEGF-A gene consists of eight exons that undergoes alternative exon splicing and produce five different proteins consisting of 121, 145, 165, 189 and 206 amino acids (named VEGF121, VEGF145, VEGF165, VEGF189, and VEGF206).
METHODS: In this study, VEGF121 gene synthesized and cloned into the pET-26b plasmid. The recombinant plasmid was transferred into appropriate expression strain of BL-21. Expression of VEGF121 induced by IPTG (Isopropyl β-D-1-thiogalactopyranoside) and confirmed by SDS-PAGE and Western-Blotting. Recombinant VEGF121 was purified by nickel affinity chromatography. HUVECs (Human Umbilical Vein Endothelia Cells) cells were isolated from umbilical vein and the effect of VEGF121 on tube formation of endothelial cells was investigated.
RESULTS: SDS-PAGE and Western-Blotting results verified the purification of VEGF121. The final yield of recombinant protein was about 5mg per liter. Endothelial cell tube formation assay results showed that VEGF121 leads to tube formation of endothelial cell on matrix and induces angiogenesis in vitro.
CONCLUSION: Recombinant VEGF121 is important factor in tube formation of endothelial cell, so it could be used in different cancer researches and angiogenesis assay.

Entities:  

Keywords:  Angiogenesis; Endothelial tube formation assay; VEGF121

Year:  2014        PMID: 25436186      PMCID: PMC4137420          DOI: 10.5681/apb.2014.047

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  26 in total

Review 1.  The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art.

Authors:  Irina Arnaoutova; Jay George; Hynda K Kleinman; Gabriel Benton
Journal:  Angiogenesis       Date:  2009-04-28       Impact factor: 9.596

2.  A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth.

Authors:  Andreas G Niethammer; Rong Xiang; Jürgen C Becker; Harald Wodrich; Ursula Pertl; Gabriele Karsten; Brian P Eliceiri; Ralph A Reisfeld
Journal:  Nat Med       Date:  2002-11-04       Impact factor: 53.440

Review 3.  Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.

Authors:  M J Karkkainen; T V Petrova
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

Review 4.  Nanobody; an old concept and new vehicle for immunotargeting.

Authors:  Fatemeh Rahbarizadeh; Davoud Ahmadvand; Zahra Sharifzadeh
Journal:  Immunol Invest       Date:  2011-01-11       Impact factor: 3.657

5.  Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.

Authors:  Christian Fischer; Bart Jonckx; Massimiliano Mazzone; Serena Zacchigna; Sonja Loges; Lucia Pattarini; Emmanuel Chorianopoulos; Laurens Liesenborghs; Marta Koch; Maria De Mol; Monica Autiero; Sabine Wyns; Stephane Plaisance; Lieve Moons; Nico van Rooijen; Mauro Giacca; Jean-Marie Stassen; Mieke Dewerchin; Desire Collen; Peter Carmeliet
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

6.  VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade.

Authors:  John S Rudge; Jocelyn Holash; Donna Hylton; Michelle Russell; Shelly Jiang; Raymond Leidich; Nicholas Papadopoulos; Erica A Pyles; Al Torri; Stanley J Wiegand; Gavin Thurston; Neil Stahl; George D Yancopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-13       Impact factor: 11.205

Review 7.  Angiogenesis: an organizing principle for drug discovery?

Authors:  Judah Folkman
Journal:  Nat Rev Drug Discov       Date:  2007-04       Impact factor: 84.694

Review 8.  Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".

Authors:  Janusz Rak; Joanne L Yu
Journal:  Semin Cancer Biol       Date:  2004-04       Impact factor: 15.707

Review 9.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

Review 10.  In vitro models of angiogenesis: the use of Matrigel.

Authors:  R Benelli; A Albini
Journal:  Int J Biol Markers       Date:  1999 Oct-Dec       Impact factor: 3.248

View more
  13 in total

1.  Soluble Production of Human Recombinant VEGF-A121 by Using SUMO Fusion Technology in Escherichia coli.

Authors:  Rufus Vinod Munawar Samuel; Syeda Yumna Farrukh; Sadia Rehmat; Muhammad Umair Hanif; Syed Shoaib Ahmed; Syed Ghulam Musharraf; Faiza Gul Durrani; Mahjabeen Saleem; Roquyya Gul
Journal:  Mol Biotechnol       Date:  2018-08       Impact factor: 2.695

2.  Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization.

Authors:  E Alirahimi; A Ashkiyan; F Kazemi-Lomedasht; K Azadmanesh; M Hosseininejad-Chafi; M Habibi-Anbouhi; R Moazami; M Behdani
Journal:  Cancer Gene Ther       Date:  2016-12-16       Impact factor: 5.987

3.  Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature.

Authors:  Roshank Ahani; Farzin Roohvand; Reza Ahangari Cohan; Mohammad Hossein Etemadzadeh; Nasir Mohajel; Mahdi Behdani; Zahra Shahosseini; Navid Madani; Kayhan Azadmanesh
Journal:  Mol Biotechnol       Date:  2016-11       Impact factor: 2.695

4.  A Novel Immunotoxin Targeting Epithelial Cell Adhesion Molecule Using Single Domain Antibody Fused to Diphtheria Toxin.

Authors:  Reyhaneh Roshan; Shamsi Naderi; Mahdi Behdani; Reza Ahangari Cohan; Fatemeh Kazemi-Lomedasht
Journal:  Mol Biotechnol       Date:  2022-09-21       Impact factor: 2.860

5.  Expression of Functional Recombinant Human Tissue Transglutaminase (TG2) Using the Bac-to-Bac Baculovirus Expression System.

Authors:  Yaghoub Yazdani; Shahram Azari; Hamid Reza Kalhor
Journal:  Adv Pharm Bull       Date:  2016-03-17

6.  Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli.

Authors:  Kamal Veisi; Safar Farajnia; Nosratollah Zarghami; Hamid Reza Khoram Khorshid; Nasser Samadi; Shiva Ahdi Khosroshahi; Hossein Zarei Jaliani
Journal:  Adv Pharm Bull       Date:  2015-12-31

7.  Apoplastic Production of Recombinant AntiVEGF Protein Using Plant-Virus Transient Expression Vector.

Authors:  Mojgan Soleimanizadeh; Mokhtar Jalali Javaran; Abdolreza Bagheri; Mahdi Behdani
Journal:  Mol Biotechnol       Date:  2022-03-24       Impact factor: 2.860

8.  Enhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF121 Expressed in E. coli Origami B (DE3) with Molecular Chaperones.

Authors:  Ondřej Kaplan; Jana Zárubová; Barbora Mikulová; Elena Filová; Jiřina Bártová; Lucie Bačáková; Eduard Brynda
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

9.  MiR-103 regulates the angiogenesis of ischemic stroke rats by targeting vascular endothelial growth factor (VEGF).

Authors:  Fu-Ping Shi; Xue-Hong Wang; Hong-Xin Zhang; Meng-Meng Shang; Xiao-Xi Liu; Hai-Min Sun; Yue-Ping Song
Journal:  Iran J Basic Med Sci       Date:  2018-03       Impact factor: 2.699

10.  Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function.

Authors:  Fatemeh Kazemi-Lomedasht; Serge Muyldermans; Mahdi Habibi-Anbouhi; Mahdi Behdani
Journal:  Iran J Basic Med Sci       Date:  2018-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.